glp-1 news today recency 3 New oral drug delivers up to 12% weight loss in 36 weeks What's next for GLP-1 innovation:

People with a history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 should avoid these medications due to the potential risk of thyroid tumors

The injections don't independently cause fat loss

The optimal product should deliver holistic nutrient density: low volume, high protein and fibre including a variety of fibre types a source of essential fats, and a source of multiple vitamins and minerals, particularly calcium, iron, zinc, magnesium and a variety of B vitamins

Centers for Medicare and Medicaid Services

They work by mimicking the action of the GLP-1 hormone, which regulates appetite, insulin secretion, and blood sugar levels